The duality of human oncoproteins: drivers of cancer and congenital disorders

Pau Castel, Katherine A. Rauen, Frank McCormick

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


Human oncoproteins promote transformation of cells into tumours by dysregulating the signalling pathways that are involved in cell growth, proliferation and death. Although oncoproteins were discovered many years ago and have been widely studied in the context of cancer, the recent use of high-throughput sequencing techniques has led to the identification of cancer-associated mutations in other conditions, including many congenital disorders. These syndromes offer an opportunity to study oncoprotein signalling and its biology in the absence of additional driver or passenger mutations, as a result of their monogenic nature. Moreover, their expression in multiple tissue lineages provides insight into the biology of the proto-oncoprotein at the physiological level, in both transformed and unaffected tissues. Given the recent paradigm shift in regard to how oncoproteins promote transformation, we review the fundamentals of genetics, signalling and pathogenesis underlying oncoprotein duality.

Original languageEnglish (US)
Pages (from-to)383-397
Number of pages15
JournalNature Reviews Cancer
Issue number7
StatePublished - Jul 1 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'The duality of human oncoproteins: drivers of cancer and congenital disorders'. Together they form a unique fingerprint.

Cite this